Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of central nervous system agents. Its structure supports the creation of bioactive molecules due to the presence of both the trifluoromethyl group and the benzylamine moiety, which can enhance metabolic stability and receptor binding affinity. Commonly employed in medicinal chemistry for optimizing lead compounds in drug discovery programs.